CXCL9 and neoplasm: CD40 agonist also increased Cxcl9/Cxcl10 in KPC2a tumors and Cxcl9/Cxcl10 colocalized with both tumor-associated macrophages (TAMs) and tumor cells (Supplementary Fig. 2G-H).